Physician profile
Gregory Bennett
NPI 1376819524
$2,381.50
in general payments reported to CMS, 2019-2025
12 companies · $59.26 in 2025
The $59.26 reported for 2025 was less than what a typical Allergy & Immunology provider received nationally (typical 2025 total: $1,138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $154 · 2021: $74.40 · 2022: $32.51 · 2023: $239 · 2024: $1,822 · 2025: $59.26.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,320 · Food and Beverage: $785 · Education: $15.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,320.00 |
| Food and Beverage | $785.30 |
| Education | $15.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $1,868.59 | 2021-2024 | |
| Regeneron Healthcare Solutions, INC. | $255.04 | 2022-2024 | Dupixent |
| Astrazeneca Pharmaceuticals Lp | $55.75 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $47.87 | 2019-2025 | |
| Intersect Ent, INC. | $42.40 | 2019 | |
| Csl Behring | $25.00 | 2019 | |
| Abbott Laboratories | $23.82 | 2025 | Freestyle Libre 3 |
| Teva Pharmaceuticals USA, INC. | $17.76 | 2022 | |
| Pfizer INC. | $15.27 | 2023 | |
| Optinose US, INC. | $15.07 | 2025 | |
| Kaleo, INC. | $14.93 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$59,023.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Bennett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.